Nuclear Medicine/ Radiopharmaceuticals Market Size, Share, Growth, Outlook, Analysis and Forecast 2017 To 2025: Credence Research

News, Press Release Comments Off on Nuclear Medicine/ Radiopharmaceuticals Market Size, Share, Growth, Outlook, Analysis and Forecast 2017 To 2025: Credence Research

According to the latest market report published by Credence Research, Inc. “Nuclear Medicine/ Radiopharmaceuticals Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global nuclear medicine/ radiopharmaceuticals market was valued at US$ 4.82 Bn in 2016, and is expected to reach US$ 7.78 Bn by 2025, expanding at a CAGR of 5.5% from 2017 to 2025.

Browse the full report report at http://www.credenceresearch.com/report/nuclear-medicine-radiopharmaceuticals-market

Market Insights

Nuclear medicine/ radiopharmaceuticals is a drug that can be used either for diagnostic or therapeutic purposes. Advantage such as targeted therapeutic irradiation with lower adverse effects and cost effective treatment option are prime factors that are driving the nuclear medicine/radiopharmaceuticals market growth. Nuclear medicine/ radiopharmaceuticals is segmented on the basis of application such as therapeutic (thyroid, oncology, bone metastasis and other applications) and diagnostics application (cardiology, thyroid, oncology and other therapeutic application). It is estimated that, therapeutic application will show fastest market growth during forecast period due to its advantages over the traditional drug therapies such as targeted therapeutic action and lower side effects. Radiopharmaceuticals applications in cardiology and oncology is anticipated to grow significantly during forecast period due to its increasing applicability in diagnosis of the disease; furthermore, growing prevalence of these disease will fuel the market growth. Radiopharmaceuticals market is categorized on the basis of type such as diagnostics radiopharmaceuticals (SPECT and PET) and therapeutic Radiopharmaceutical (beta emitter, alpha emitter and brachytherapy). It is observed that, in the base year 2016, diagnostic radiopharmaceutical is major revenue generating segment, due to the rising incidence of cancer and cardiac disease, improved affordability, more precise technique and advancement in PET and SPECT scan. Radiopharmaceuticals market is currently dominated by North America due to technological advancement, higher investment in R&D activities, presence of large number of biopharmaceutical industries and research institutes. However, Asia Pacific will show fastest market growth due to increasing government investments in the life sciences sector and increasing partnership of key players with local manufacturer, and rapidly expanding life science industries will witness phenomenal growth.

Click Here To Download Full Report Sample on Nuclear Medicine/ Radiopharmaceuticals Market: http://www.credenceresearch.com/sample-request/58722

Market Competition Assessment:

The nuclear medicine/ radiopharmaceuticals market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Advanced Accelerator Applications S.A., Bayer AG, Bracco Imaging S.p.A., Cardinal Health, Inc., GE Healthcare, IBA Molecular Imaging, Lantheus Medical Imaging Inc., Mallinckrodt plc., Medtronic, plc., Nordion, Inc., NTP Radioisotopes SOC Ltd., Segami Corporation and others.

Key Market Movements:

  • Factors such as increase in number of chronic disease, technological advancement and increasing awareness of radiopharmaceuticals are primarily driving the growth of nuclear medicine/ radiopharmaceuticals market globally
  • The major opportunity radiopharmaceutical market is due to high unmet needs for treatment of various forms of cancer and this would expected to drive the nuclear medicine/ radiopharmaceuticals market growth during forecast period.

Browse the full report report at http://www.credenceresearch.com/report/nuclear-medicine-radiopharmaceuticals-market

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,

CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com\

Author

Back to Top